Literature DB >> 17050603

Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.

Anna R Ciccaglione1, Emilia Stellacci, Cinzia Marcantonio, Valentina Muto, Michele Equestre, Giulia Marsili, Maria Rapicetta, Angela Battistini.   

Abstract

Hepatitis C virus (HCV) proteins are known to interfere at several levels with both innate and adaptive responses of the host. A key target in these effects is the interferon (IFN) signaling pathway. While the effects of nonstructural proteins are well established, the role of structural proteins remains controversial. We investigated the effect of HCV structural proteins on the expression of interferon regulatory factor 1 (IRF-1), a secondary transcription factor of the IFN system responsible for inducing several key antiviral and immunomodulatory genes. We found substantial inhibition of IRF-1 expression in cells expressing the entire HCV replicon. Suppression of IRF-1 synthesis was mainly mediated by the core structural protein and occurred at the transcriptional level. The core protein in turn exerted a transcriptional repression of several interferon-stimulated genes, targets of IRF-1, including interleukin-15 (IL-15), IL-12, and low-molecular-mass polypeptide 2. These data recapitulate in a unifying mechanism, i.e., repression of IRF-1 expression, many previously described pathogenetic effects of HCV core protein and suggest that HCV core-induced IRF-1 repression may play a pivotal role in establishing persistent infection by dampening an effective immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050603      PMCID: PMC1797261          DOI: 10.1128/JVI.01011-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

Review 1.  Roles of interferon-regulatory factors in T-helper-cell differentiation.

Authors:  Michael Lohoff; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

2.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

3.  IFN-gamma represses IL-4 expression via IRF-1 and IRF-2.

Authors:  Bernd Elser; Michael Lohoff; Sonja Kock; Marco Giaisi; Sabine Kirchhoff; Peter H Krammer; Min Li-Weber
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

4.  Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Authors:  Adrien Breiman; Nathalie Grandvaux; Rongtuan Lin; Catherine Ottone; Shizuo Akira; Mitsutoshi Yoneyama; Takashi Fujita; John Hiscott; Eliane F Meurs
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response.

Authors:  Keith D Tardif; Kazutoshi Mori; Randal J Kaufman; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

Review 6.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 7.  Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight.

Authors:  Luca Parente; Mauro Perretti
Journal:  Biochem Pharmacol       Date:  2003-01-15       Impact factor: 5.858

8.  Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Authors:  Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

9.  Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.

Authors:  Michael Frese; Verena Schwärzle; Kerstin Barth; Nicole Krieger; Volker Lohmann; Sabine Mihm; Otto Haller; Ralf Bartenschlager
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

10.  Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression.

Authors:  J C Blanco; C Contursi; C A Salkowski; D L DeWitt; K Ozato; S N Vogel
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  22 in total

1.  Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells.

Authors:  Vania Bonifaz; Ying Shan; Richard W Lambrecht; Susan E Donohue; Darcy Moschenross; Herbert L Bonkovsky
Journal:  Liver Int       Date:  2008-08-07       Impact factor: 5.828

2.  Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Donavan T Cheng; Palanikumar Ravindran; Hans Bitter; Lore Gruenbaum; Paul J Cote; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

Review 3.  Impact of host and virus genome variability on HCV replication and response to interferon.

Authors:  Cameron J Schweitzer; T Jake Liang
Journal:  Curr Opin Virol       Date:  2013-07-06       Impact factor: 7.090

Review 4.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

5.  Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.

Authors:  Valentina Muto; Emilia Stellacci; Angelo Giuseppe Lamberti; Edvige Perrotti; Aurora Carrabba; Giovanni Matera; Marco Sgarbanti; Angela Battistini; Maria Carla Liberto; Alfredo Focà
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

6.  Identification and characterization of interferon regulatory factor-1 from orange-spotted grouper (Epinephelus coioides).

Authors:  Yan Shi; Xin-Ping Zhu; Jing-Kui Yin; Qi-Ya Zhang; Jian-Fang Gui
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

7.  Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.

Authors:  Nandini Sen; Phillip Sung; Arjun Panda; Ann M Arvin
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

8.  Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.

Authors:  Shelly J Robertson; Kirk J Lubick; Brett A Freedman; Aaron B Carmody; Sonja M Best
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

9.  An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones.

Authors:  Roberto Bruni; Cinzia Marcantonio; Elena Tritarelli; Paola Tataseo; Emilia Stellacci; Angela Costantino; Umbertina Villano; Angela Battistini; Anna Rita Ciccaglione
Journal:  BMC Genomics       Date:  2011-10-04       Impact factor: 3.969

10.  Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.

Authors:  Hangeun Kim; Budhaditya Mazumdar; Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.